Poolbeg Pharma PLC (POLB) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.251x

Based on the latest financial reports, Poolbeg Pharma PLC (POLB) has a cash flow conversion efficiency ratio of -0.251x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-2.16 Million ≈ $-263.05 USD) by net assets (GBX8.60 Million ≈ $1.05K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Poolbeg Pharma PLC stock valuation for the company's overall valuation and market capitalisation.

Poolbeg Pharma PLC - Cash Flow Conversion Efficiency Trend (2021–2025)

This chart illustrates how Poolbeg Pharma PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Poolbeg Pharma PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Poolbeg Pharma PLC ranked by their cash flow conversion efficiency. See Poolbeg Pharma PLC cash flow to debt ratio to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Jade Leader Corp V:JADE	-0.072x
Michelmersh Brick Holdings Plc LSE:MBH	0.020x
Maven Income And Growth Vct Plc LSE:MIG1	-0.003x
Hansard Global Plc LSE:HSD	-0.013x
Insplorion AB ST:INSP	-0.139x
Aurora Solar Technologies Inc V:ACU	0.477x
Corero Network Security plc LSE:CNS	-0.046x
Black Widow Resources Inc V:BWR	-0.006x

Annual Cash Flow Conversion Efficiency for Poolbeg Pharma PLC (2021–2025)

The table below shows the annual cash flow conversion efficiency of Poolbeg Pharma PLC from 2021 to 2025. View Poolbeg Pharma PLC (POLB) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	GBX8.60 Million ≈ $1.05K	GBX-4.51 Million ≈ $-548.49	-0.524x	-4.61%
2024-12-31	GBX9.27 Million ≈ $1.13K	GBX-4.65 Million ≈ $-565.28	-0.501x	-65.16%
2023-12-31	GBX14.44 Million ≈ $1.76K	GBX-4.38 Million ≈ $-533.04	-0.303x	-27.25%
2022-12-31	GBX18.32 Million ≈ $2.23K	GBX-4.37 Million ≈ $-531.46	-0.238x	-150.83%
2021-12-31	GBX22.58 Million ≈ $2.75K	GBX-2.15 Million ≈ $-261.11	-0.095x	--

About Poolbeg Pharma PLC

LSE:POLB UK Biotechnology

Market Cap

$808.13K

GBX6.64 Billion GBX

Market Cap Rank

#30814 Global

#844 in UK

Share Price

GBX8.70

Change (1 day)

+3.57%

52-Week Range

GBX3.30 - GBX9.00

All Time High

GBX14.90